Literature DB >> 19107105

Why do patients on peritoneal dialysis have low blood levels of protein-bound solutes?

Raymond Vanholder1, Natalie Meert, Wim Van Biesen, Timothy Meyer, Thomas Hostetter, Annemieke Dhondt, Sunny Eloot.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 19107105     DOI： 10.1038/ncpneph1023

Source DB:  PubMed          Journal:  Nat Clin Pract Nephrol        ISSN： 1745-8323


× No keyword cloud information.
  9 in total

Review 1.  Review on uremic toxins: classification, concentration, and interindividual variability.

Authors:  Raymond Vanholder; Rita De Smet; Griet Glorieux; Angel Argilés; Ulrich Baurmeister; Philippe Brunet; William Clark; Gerald Cohen; Peter Paul De Deyn; Reinhold Deppisch; Beatrice Descamps-Latscha; Thomas Henle; Achim Jörres; Horst Dieter Lemke; Ziad A Massy; Jutta Passlick-Deetjen; Mariano Rodriguez; Bernd Stegmayr; Peter Stenvinkel; Ciro Tetta; Christoph Wanner; Walter Zidek
Journal:  Kidney Int       Date:  2003-05       Impact factor: 10.612

2.  Superior dialytic clearance of beta(2)-microglobulin and p-cresol by high-flux hemodialysis as compared to peritoneal dialysis.

Authors:  P Evenepoel; B Bammens; K Verbeke; Y Vanrenterghem
Journal:  Kidney Int       Date:  2006-07-05       Impact factor: 10.612

Review 3.  Uremia.

Authors:  Timothy W Meyer; Thomas H Hostetter
Journal:  N Engl J Med       Date:  2007-09-27       Impact factor: 91.245

4.  An evaluation of an integrative care approach for end-stage renal disease patients.

Authors:  Wim VAN Biesen; Raymond C Vanholder; Nic Veys; Annemieke Dhondt; Norbert H Lameire
Journal:  J Am Soc Nephrol       Date:  2000-01       Impact factor: 10.121

5.  Removal of P-cresol sulfate by hemodialysis.

Authors:  Andres W Martinez; Natalie S Recht; Thomas H Hostetter; Timothy W Meyer
Journal:  J Am Soc Nephrol       Date:  2005-08-24       Impact factor: 10.121

6.  Comparing the risk for death with peritoneal dialysis and hemodialysis in a national cohort of patients with chronic kidney disease.

Authors:  Bernard G Jaar; Josef Coresh; Laura C Plantinga; Nancy E Fink; Michael J Klag; Andrew S Levey; Nathan W Levin; John H Sadler; Alan Kliger; Neil R Powe
Journal:  Ann Intern Med       Date:  2005-08-02       Impact factor: 25.391

Review 7.  Uremic toxins and peritoneal dialysis.

Authors:  N Lameire; R Vanholder; R De Smet
Journal:  Kidney Int Suppl       Date:  2001-02       Impact factor: 10.545

8.  Free p-cresol is associated with cardiovascular disease in hemodialysis patients.

Authors:  B K I Meijers; B Bammens; B De Moor; K Verbeke; Y Vanrenterghem; P Evenepoel
Journal:  Kidney Int       Date:  2008-02-27       Impact factor: 10.612

9.  Removal of the protein-bound solutes indican and p-cresol sulfate by peritoneal dialysis.

Authors:  Nhat M Pham; Natalie S Recht; Thomas H Hostetter; Timothy W Meyer
Journal:  Clin J Am Soc Nephrol       Date:  2007-11-28       Impact factor: 8.237
  9 in total
  8 in total

1.  Contribution of residual function to removal of protein-bound solutes in hemodialysis.

Authors:  Ilian O Marquez; Shouieb Tambra; Frank Y Luo; You Li; Natalie S Plummer; Thomas H Hostetter; Timothy W Meyer
Journal:  Clin J Am Soc Nephrol       Date:  2010-10-28       Impact factor: 8.237

2.  Prominent accumulation in hemodialysis patients of solutes normally cleared by tubular secretion.

Authors:  Tammy L Sirich; Benjamin A Funk; Natalie S Plummer; Thomas H Hostetter; Timothy W Meyer
Journal:  J Am Soc Nephrol       Date:  2013-11-14       Impact factor: 10.121

3.  Serum concentrations of p-cresyl sulfate and indoxyl sulfate, but not inflammatory markers, increase in incident peritoneal dialysis patients in parallel with loss of residual renal function.

Authors:  Liesbeth Viaene; Björn K I Meijers; Bert Bammens; Yves Vanrenterghem; Pieter Evenepoel
Journal:  Perit Dial Int       Date:  2013-10-31       Impact factor: 1.756

Review 4.  Once upon a time in dialysis: the last days of Kt/V?

Authors:  Raymond Vanholder; Griet Glorieux; Sunny Eloot
Journal:  Kidney Int       Date:  2015-06-10       Impact factor: 10.612

Review 5.  An update on uremic toxins.

Authors:  N Neirynck; R Vanholder; E Schepers; S Eloot; A Pletinck; G Glorieux
Journal:  Int Urol Nephrol       Date:  2012-08-15       Impact factor: 2.370

6.  White adipose tissue overproduces the lipid-mobilizing factor zinc α2-glycoprotein in chronic kidney disease.

Authors:  Caroline C Pelletier; Laetitia Koppe; Marine L Croze; Emilie Kalbacher; Roxane E Vella; Fitsum Guebre-Egziabher; Alain Géloën; Lionel Badet; Denis Fouque; Christophe O Soulage
Journal:  Kidney Int       Date:  2013-02-20       Impact factor: 10.612

Review 7.  p-Cresyl Sulfate.

Authors:  Tessa Gryp; Raymond Vanholder; Mario Vaneechoutte; Griet Glorieux
Journal:  Toxins (Basel)       Date:  2017-01-29       Impact factor: 4.546

Review 8.  Review of the structural and functional brain changes associated with chronic kidney disease.

Authors:  M Michna; L Kovarova; A Valerianova; H Malikova; J Weichet; J Malik
Journal:  Physiol Res       Date:  2020-11-02       Impact factor: 1.881
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.